Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models
Crossref DOI link: https://doi.org/10.1007/s12015-017-9720-x
Published Online: 2017-02-23
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carvalho, Mariana R.
Lima, Daniela
Reis, Rui L.
Oliveira, Joaquim M.
Correlo, Vitor M.
Funding for this research was provided by:
QREN (FP7/2007-2013)
FCT (IF/00423/2012, IF/01214/2014)
Norte 2020 (NORTE-08-5369-FSE-000044)
License valid from 2017-02-23